144 related articles for article (PubMed ID: 25085212)
41. Additional postbypass administration of tranexamic acid reduces blood loss after cardiac operations.
Katoh J; Tsuchiya K; Sato W; Nakajima M; Iida Y
J Thorac Cardiovasc Surg; 1997 Apr; 113(4):802-4. PubMed ID: 9104995
[No Abstract] [Full Text] [Related]
42. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
43. The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty.
Wind TC; Barfield WR; Moskal JT
J Arthroplasty; 2014 Feb; 29(2):387-9. PubMed ID: 23790499
[TBL] [Abstract][Full Text] [Related]
44. Tranexamic acid: still far to go.
Goobie SM
Br J Anaesth; 2017 Mar; 118(3):293-295. PubMed ID: 28203768
[No Abstract] [Full Text] [Related]
45. Evaluation of the efficacy of tranexamic acid on blood loss in orthognathic surgery. A prospective, randomized clinical study.
Sankar D; Krishnan R; Veerabahu M; Vikraman B
Int J Oral Maxillofac Surg; 2012 Jun; 41(6):713-7. PubMed ID: 22340993
[TBL] [Abstract][Full Text] [Related]
46. Comment on "Clinical observation of blood loss reduced by tranexamic acid during and after cesarian section: a multi-center, randomized trial (Eur J Obstet Gynecol Reprod Biol 2004; 112: 154-57)".
Kafali H
Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):240; author reply 240-1. PubMed ID: 15358477
[No Abstract] [Full Text] [Related]
47. Tranexamic acid as a means of reducing the need for blood and blood component therapy in children undergoing open heart surgery for congenital cyanotic heart disease.
Vacharaksa K; Prakanrattana U; Suksompong S; Chumpathong S
J Med Assoc Thai; 2002 Sep; 85 Suppl 3():S904-9. PubMed ID: 12452228
[TBL] [Abstract][Full Text] [Related]
48. Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study.
Caglar GS; Tasci Y; Kayikcioglu F; Haberal A
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):227-31. PubMed ID: 17499419
[TBL] [Abstract][Full Text] [Related]
49. Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.
Peitsidis P; Kadir RA
Expert Opin Pharmacother; 2011 Mar; 12(4):503-16. PubMed ID: 21294602
[TBL] [Abstract][Full Text] [Related]
50. Comparison of blood-sparing efficacy of ε-aminocaproic acid and tranexamic acid in newborns undergoing cardiac surgery.
Martin K; Gertler R; Sterner A; MacGuill M; Schreiber C; Hörer J; Vogt M; Tassani P; Wiesner G
Thorac Cardiovasc Surg; 2011 Aug; 59(5):276-80. PubMed ID: 21425054
[TBL] [Abstract][Full Text] [Related]
51. Antifibrinolytics in liver transplantation.
Groenland TH; Porte RJ
Int Anesthesiol Clin; 2006; 44(3):83-97. PubMed ID: 16832208
[No Abstract] [Full Text] [Related]
52. Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study.
Lundin ES; Johansson T; Zachrisson H; Leandersson U; Bäckman F; Falknäs L; Kjølhede P
Acta Obstet Gynecol Scand; 2014 Apr; 93(4):335-44. PubMed ID: 24428857
[TBL] [Abstract][Full Text] [Related]
53. [Percutaneous nephrolithotomy - tranexamic acid reduces blood loss].
Ritter M; Michel MS
Aktuelle Urol; 2013 Nov; 44(6):428-9. PubMed ID: 24281930
[No Abstract] [Full Text] [Related]
54. Tranexamic Acid reduces perioperative blood loss in adult patients having spinal fusion surgery.
Wong J; El Beheiry H; Rampersaud YR; Lewis S; Ahn H; De Silva Y; Abrishami A; Baig N; McBroom RJ; Chung F
Anesth Analg; 2008 Nov; 107(5):1479-86. PubMed ID: 18931202
[TBL] [Abstract][Full Text] [Related]
55. Intraoperative tranexamic acid reduces blood transfusion in children undergoing craniosynostosis surgery: a randomized double-blind study.
Dadure C; Sauter M; Bringuier S; Bigorre M; Raux O; Rochette A; Canaud N; Capdevila X
Anesthesiology; 2011 Apr; 114(4):856-61. PubMed ID: 21358317
[TBL] [Abstract][Full Text] [Related]
56. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
[TBL] [Abstract][Full Text] [Related]
57. Comparison of intra-operative regimes of tranexamic acid administration in primary total hip replacement.
Machin JT; Batta V; Soler JA; Sivagaganam K; Kalairajah Y
Acta Orthop Belg; 2014 Jun; 80(2):228-33. PubMed ID: 25090797
[TBL] [Abstract][Full Text] [Related]
58. [Tranexamic acid reduces the blood loss in knee arthroplasty--if it's administered at the right time].
Benoni G
Lakartidningen; 1999 Jun; 96(24):2967-9. PubMed ID: 10402804
[TBL] [Abstract][Full Text] [Related]
59. Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty.
Kelley TC; Tucker KK; Adams MJ; Dalury DF
Transfusion; 2014 Jan; 54(1):26-30. PubMed ID: 23521109
[TBL] [Abstract][Full Text] [Related]
60. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
